ORIGINAL RESEARCH article

Front. Microbiol., 20 August 2025

Sec. Infectious Agents and Disease

Volume 16 - 2025 | https://doi.org/10.3389/fmicb.2025.1652011

The coordinated regulatory impact of AcsS and TpdA on biofilm formation in Vibrio parahaemolyticus

  • 1. Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China

  • 2. Department of Clinical Laboratory, Children’s Hospital of Soochow University, Suzhou, China

  • 3. Department of Clinical Laboratory, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China

  • 4. Health Commission of Qinghai Province, Xining, China

Abstract

Vibrio parahaemolyticus, a marine pathogen, employs biofilm formation to enhance environmental persistence and transmission. Biofilm development is intricately regulated by cyclic di-GMP (c-di-GMP), whose levels are controlled by diguanylate cyclases (DGCs) and phosphodiesterases (PDEs). This study elucidates the coordinated regulatory roles of the LysR-type transcriptional regulator AcsS and the PDE TpdA in biofilm formation. Through genetic, transcriptomic, and biochemical analyses, we demonstrate that AcsS promotes biofilm formation by directly activating the exopolysaccharide biosynthesis gene cpsA and indirectly repressing tpdA, a gene encoding a c-di-GMP-degrading enzyme. Conversely, TpdA inhibits acsS expression and antagonizes cpsA transcription. RNA-seq revealed that AcsS globally regulates 235 genes, including those linked to flagella, type IV pili, and capsular polysaccharides. Intracellular c-di-GMP quantification showed that AcsS elevates c-di-GMP levels, while TpdA reduces them, establishing a feedback loop. Phenotypic assays confirmed that AcsS-dependent biofilm enhancement operates independently of TpdA, though TpdA partially suppresses biofilm formation in the absence of AcsS. These findings unveil a regulatory circuit where AcsS and TpdA coordinately modulate c-di-GMP metabolism and biofilm-associated gene expression, highlighting them as promising targets for disrupting biofilm-mediated persistence and transmission of V. parahaemolyticus.

Introduction

Vibrio parahaemolyticus (V. parahaemolyticus) is a bacterium that thrives in marine ecosystems (). It poses a health risk primarily through the consumption of contaminated seafood, and to a lesser extent, via contact with seawater through small open wounds (). Additionally, this bacterium is capable of forming biofilms on a range of surfaces, including those found on seafood products (). Biofilms are bacterial communities encased in a matrix that forms on surfaces and are widely utilized by numerous bacterial species to enhance environmental fitness and facilitate transmission (Yildiz and Visick, 2009; ). The biofilm matrix, which constitutes over 90% of the mass of a biofilm, is predominantly composed of exopolysaccharides (EPS), extracellular proteins, extracellular DNA, and lipids, with EPS being a particularly significant component (). In V. parahaemolyticus, the production of EPS is linked to the cpsA-K (VPA1403-1413) and scvA-O operons (). Deletion of either operon leads to a decrease in biofilm formation (). Specifically, the cpsA-K operon, rather than the scvA-O operon, is directly correlated with the transition between wrinkled and smooth colony morphologies in V. parahaemolyticus, with the wrinkled variant associated with increased EPS production (). Furthermore, additional structures, including flagella and type IV pili, also influence the biofilm formation of V. parahaemolyticus (Yildiz and Visick, 2009).

Biofilm formation is tightly regulated by numerous factors, with the secondary messenger cyclic dimeric GMP (c-di-GMP) being of central relevance. Elevated levels of c-di-GMP typically enhance biofilm formation while simultaneously suppressing motility (Yildiz and Visick, 2009). The synthesis of c-di-GMP is facilitated by the GGDEF domain present in diguanylate cyclases (DGCs), while its degradation is mediated by the EAL or HD-GYP domain found in phosphodiesterases (PDEs) (). In V. parahaemolyticus, proteins with both GGDEF and EAL domains, such as ScrC and ScrG, as well as those with only the EAL domain, like LafV and TpdA, have been shown to serve as PDEs that inhibit biofilm formation and/or promote motility (; ; ; ). Furthermore, proteins harboring the GGDEF domain, including ScrM, ScrJ, ScrL, and GefA, have been identified as DGCs that either promote biofilm formation or inhibit motility (; ; Zhong et al., 2022). Additionally, VopY, an EAL domain-containing protein, degrades c-di-GMP, thereby augmenting virulence (Wu et al., 2023). The metabolism of c-di-GMP is intricately regulated by various environmental conditions, including salinity, exposure to antibiotics like chloramphenicol, and the availability of nutrients such as L-arabinose (; Zhang et al., 2023; Zhang et al., 2023). Moreover, transcriptional regulators such as OpaR, QsvR, and H-NS modulate c-di-GMP metabolism by regulating the expression of genes encoding DGCs and PDEs (Zhang et al., 2021; Xue et al., 2022; Zhang et al., 2023).

AcsS, a member of LysR-family transcriptional regulators, is significantly regulated by environmental factors, including low-salt growth conditions, the presence of L-arabinose, and incubation time (Zhang et al., 2023; Yang et al., 2010; Zhang et al., 2023). Our recent findings indicate that AcsS enhances the swimming and swarming motility of V. parahaemolyticus by activating the expression of genes associated with polar and lateral flagella (), but it inhibits the expression of major virulence determinants, such as thermostable direct hemolysin and type VI secretion system 2, by repressing the transcription of corresponding genes (; ). Notably, flagella play a crucial role in the initial stages of biofilm formation and are essential for the development of mature biofilms in V. parahaemolyticus (Yildiz and Visick, 2009; ). Therefore, AcsS is likely involved in regulating biofilm formation in V. parahaemolyticus. In this study, our data demonstrate that AcsS coordinates with TpdA to regulate biofilm formation in V. parahaemolyticus.

Materials and methods

Bacterial strains

The wild type (WT) strain RIMD2210633 of V. parahaemolyticus was utilized in this study (). Nonpolar acsS deletion mutant (ΔacsS), derived from the WT strain, was constructed by our previous study (). The complementation strain ΔacsS/pBAD33-acsS (C-ΔacsS) was constructed by introducing pBAD33-acsS into ΔacsS (). Control strains (WT/pBAD33 and ΔacsS/pBAD33) were generated by introducing pBAD33 into WT and ΔacsS, respectively. The acsS and tpdA double-gene mutant (ΔacsSΔtpdA) and the tpdA single-gene mutant (ΔtpdA) were generated via deletion of a 258-bp fragment (nucleotides 1305–1562) of tpdA from ΔacsS and WT, respectively, by homologous recombination using suicide plasmid pDS132 (). All primers used in this study are listed in Table 1.

Table 1

TargetPrimers (forward/reverse, 5′-3′)References
Construction of mutant
acsSGTGACTGCAGTTCCACTGACGGTCATCAC/CGATAGGGATAATGCGAAGGGTCTGTTCAAGTGCGATG
CATCGCACTTGAACAGACCCTTCGCATTATCCCTATCG/GTGAGCATGCGTTGTGCCAGCAAGATTTC
GTGACTGCAGTTCCACTGACGGTCATCAC/GTGAGCATGCGTTGTGCCAGCAAGATTTC
tpdAGTGACTGCAGACACCAACACAGGTACATCG/GACGCAGCGTTTCCACTTTCCCTCGTAGAAGAGAAGGGCAThis study
TGCCCTTCTCTTCTACGAGGGAAAGTGGAAACGCTGCGTC/GTGAGCATGCTGGTAAGCCTGTTCAAACGG
GTGACTGCAGACACCAACACAGGTACATCG/GTGAGCATGCTGGTAAGCCTGTTCAAACGG
Construction of complementation strain
acsSGATTCTAGAAGGAGGAATTCACCATGGATATCAAACAAC/GTGACTGCAGTTATCGATTAAATATG
RT-qPCR
cpsAGAGAGCGGCAACCTATATCG/CGCCACGCCAACAGTAATGZhang et al. (2023)
tpdAAGAATCAACCAACACACGAA/CACAATACTGTTGATGGCGTAThis study
LacZ fusion
cpsAGCGCGAGCTCCTTCCCTGTAAATAAGTCATCC/GCGCGGATCCAAGCGAACTCCATCTCATAAGZhang et al. (2023)
tpdATCGATAAGCCCGAGTGAAT/TGAGTATGCCATTCTTTCAACThis study
Two-plasmid LacZ fusion
cpsAGCGCGAGCTCCTTCCCTGTAAATAAGTCATCC/GCGCGGATCCAAGCGAACTCCATCTCATAAGZhang et al. (2023)
tpdATCGATAAGCCCGAGTGAAT/TGAGTATGCCATTCTTTCAACThis study
EMSA
cpsAGCGCGTCGACCTTCCCTGTAAATAAGTCATCC/GCGCGAATTCAAGCGAACTCCATCTCATAAGZhang et al. (2023)
tpdATCGATAAGCCCGAGTGAAT/TGAGTATGCCATTCTTTCAACThis study
16S rRNAGACACGGTCCAGACTCCTAC/GGTGCTTCTTCTGTCGCTAACZhang et al. (2023)

Primers used in this study.

Growth conditions

Unless stated otherwise, the cultivation of V. parahaemolyticus was conducted as previously described (). Briefly, V. parahaemolyticus was grown in 2.5% (w/v) Bacto heart infusion (HI) broth (BD Biosciences, New Jersey, United States) at 37 °C with shaking at 200 rpm for 12 h. The resultant culture was diluted 50-fold into 5 mL HI broth, and then incubated under the same conditions until it reached to an optical density at 600 nm (OD600) value of 1.4. This culture was referred to as the bacterial seed. Subsequently, the bacterial seed was diluted 1,000-fold into 5 mL of HI broth for a third round of growth and was harvested at an OD600 value of 1.4. When necessary, the medium was supplemented with 50 μg/mL of gentamicin, 5 μg/mL of chloramphenicol and/or 0.1% (w/v) L-arabinose.

Crystal violet staining assay

Crystal violet (CV) staining assay was performed similarly as previously described (Zhang et al., 2023). Briefly, the bacterial seed was diluted 50-fold into 2 mL of Difco marine (M) broth 2216 (BD Biosciences, New Jersey, United States), supplemented 5 μg/mL chloramphenicol and 0.1% L-arabinose, in a 24-well cell culture plate, and then incubated at 30 °C with shaking at 150 rpm for 24 h. Planktonic cells were collected for measurement of OD600 values. Surface attached biofilm cells were washed with deionized water, and then stained by 0.1% CV. Bound CV was dissolved in 2.5 mL of 20% acetic acid, and then the OD570 values were measured. The capacity for biofilm formation was expressed as the ratio of OD570 to OD600.

Colony morphology assay

For the colony morphology assay (Zhang et al., 2023), the overnight bacterial culture was diluted 50-fold into 5 mL M broth, and it was then statically incubated at 30 °C for 48 h. After thorough mixing, 2 μL of the culture was spotted onto an HI plate, or an HI plate supplemented with 5 μg/mL chloramphenicol and 0.1% (w/v) L-arabinose, and incubated at 37 °C for 48 h.

RNA isolation and RNA sequencing

The WT and ΔacsS strains were incubated under the same conditions as the CV staining assay, but without the addition of chloramphenicol and L-arabinose. Three technical replicates were conducted for each strain. Bacterial cells were harvested simultaneously from biofilms and planktonic fractions for the preparation of total RNA, which was extracted using TRIzol Reagent (Invitrogen, Massachusetts, United States) (Zhang et al., 2023). One RNA sample was prepared from each technical replicate. RNA concentration and integrity were determined by a Nanodrop 2000 and the agarose gel electrophoresis, respectively. rRNA removal and mRNA enrichment were performed using an Illumina/Ribo-Zero™ rRNA Removal Kit (bacteria) (Illumina, California, United States). All RNA-related manipulations including RNA extraction were performed in GENEWIZ Biotechnology Co. Ltd. (Suzhou, China). cDNA sequencing was performed on an Illumina Hiseq platform (Zhang et al., 2023; Zhang et al., 2022). Gene expression in ΔacsS (test group) was compared with that in WT (reference group). DESeq (v1.12.4) was used to identify the differentially expressed genes (DEGs), filtering for p ≤ 0.01 and absolute FoldChange ≥ 2. DEGs were further analyzed using the Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and Cluster of Orthologous Groups of proteins (COG) database (Zhang et al., 2023; Zhang et al., 2022).

Intracellular c-di-GMP quantification

Intracellular c-di-GMP was quantified as previously described (Zhang et al., 2023). Briefly, bacterial cells were harvested at an OD600 value of 1.4, and then they were resuspended in 2 mL ice-cold phosphate buffered saline (PBS). The bacterial suspension was incubated at 100 °C for 5 min, sonicated for 15 min, and then centrifuged at 9,000 g for 5 min. Total protein and c-di-GMP levels in the supernatant were determined using a Pierce BCA Protein Assay kit (ThermoFisher Scientific, Massachusetts, United States) and a c-di-GMP Enzyme-linked Immunosorbent Assay (ELISA) Kit (Mskbio, Hubei, China), respectively. The c-di-GMP level was expressed as pmol/g of protein.

Real-time quantitative PCR

Bacterial cells were harvested at an OD600 value of 1.4. Total RNA was extracted using TRIzol Reagent (Invitrogen, Massachusetts, United States). cDNA was generated from 1 μg of total RNA using a FastKing First Strand cDNA Synthesis Kit (Tiangen Biotech, Beijing, China). Real-time quantitative PCR (RT-qPCR) was performed using a LightCycler 480 (Roche, Basel, Switzerland) together with SYBR Green master mix (Tiangen Biotech, Beijing, China) (). The relative expression levels of each target gene were determined using the 2−ΔΔCt method, with the 16S rRNA serving as the internal control.

LacZ fusion and β-galactosidase assay

The regulatory DNA region of each target gene was cloned into pHRP309 harboring a promoterless lacZ gene and a gentamicin resistance gene (). Each recombinant plasmid was transferred into WT and its corresponding mutants. Transformants were cultured and lysed to measure the β-galactosidase activity of the cellular extracts using a β-Galactosidase Enzyme Assay System (Promega, Wisconsin, USA). Miller Units representing the β-galactosidase activity was calculated as previously described (Zhang et al., 2023). For the two-plasmid lacZ reporter assay (Zhang et al., 2023), the recombinant pHRP309 was transferred into Escherichia coli 100 λpir (EC100; Epicenter, Wisconsin, USA) bearing pBAD33-acsS or pBAD33. The transformants were cultured in Luria-Bertani (LB) broth containing 0.1% L-arabinose and 20 μg/mL chloramphenicol at 37 °C with shaking at 200 rpm. Bacterial cells were harvested at an OD600 value of 1.2, and then lysed to measure the β-galactosidase activity in the cell extracts.

Purification of 6 × His-AcsS and electrophoretic mobility-shift assay

The coding region of acsS was cloned into pET28a (Novagen, Darmstadt, Germany). The recombinant pET28a plasmid was transferred into E. coli BL21λDE3 to express the His-tagged AcsS protein (His-AcsS). Expression and purification of His-AcsS were performed as previously described for His-OpaR (). The purity of His-AcsS was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The concentration of His-AcsS solution was determined using a Pierce BCA Protein Assay kit. Purified His-AcsS was stored at −60 °C.

For electrophoretic mobility-shift assay (EMSA) (Zhang et al., 2023), the regulatory DNA region of each target gene was amplified by PCR. EMSA was performed in a 10 μL reaction volume containing 0.5 mM EDTA, 1 mM MgCl2, 50 mM NaCl, 0.5 mM DTT, 10 mM Tris–HCl (pH 7.5), 0.625 μg/mL salmon sperm DNA, 100 ng target DNA, and a certain amount of His-AcsS. After incubation at room temperature for 20 min, the binding reactions were visualized on a native polyacrylamide gel, which was stained with ethidium bromide and analyzed using a UV transilluminator.

Replicates and statistical methods

The CV staining, colony morphology assay, c-di-GMP measurement, LacZ fusion assay, RT-qPCR, and two-plasmid lacZ fusion assay were performed at least three times, with at least three technical replicates each time. EMSA for each target gene was performed at least two times, independently. The numerical results were expressed as the mean ± standard deviation (SD). To calculate statistical significance, Student’s t-tests or two-way ANOVA with Tukey’s post hoc corrections were applied, considering a p value of less than 0.05 as significant.

Results

AcsS promotes biofilm formation by Vibrio parahaemolyticus

AcsS is involved in promoting the swimming and swarming motility of V. parahaemolyticus, which are required for mature biofilm formation (; ). We therefore investigated the potential regulatory role of AcsS in biofilm formation by V. parahaemolyticus. As depicted in Figure 1a, the ΔacsS/pBAD33 strain displayed remarkably reduced CV staining compared to both the WT/pBAD33 and C-ΔacsS strains (p < 0.01). Notably, the C-ΔacsS strain demonstrated a restored CV staining pattern indicative of biofilm formation. Additionally, the colony of ΔacsS appeared smoother than that of WT (Figure 1b). Moreover, the colonies of both WT/pBAD33 and C-ΔacsS appeared smoother than that of WT. This observation may be attributed to the significant influence of chloramphenicol and L-arabinose on this particular phenotype (Zhang et al., 2023; Zhang et al., 2023). While the colony morphology of C-ΔacsS and WT/pBAD33 appeared quite different, both exhibited a more wrinkled appearance compared to ΔacsS/pBAD33. Since mutation of acsS does not affect the growth of V. parahaemolyticus (), these results indicate that AcsS positively regulates biofilm formation in V. parahaemolyticus.

Figure 1

Screening for potential target genes of AcsS involved in biofilm formation using RNA-seq

To determine the regulatory mechanism of AcsS on biofilm formation in V. parahaemolyticus, RNA sequencing (RNA-seq) analysis was performed comparing the ΔacsS (test) and WT (reference) strains. As shown in Figure 2a and detailed in Supplementary Table S1, 235 genes were identified as regulated by AcsS under biofilm growth conditions. Of these, 78 genes were upregulated and 157 genes were downregulated, in ΔacsS compared to WT. GO term enrichment analysis indicated that DEGs were associated with molecular functions (7 GO terms, 29 DEGs), cellular components (5 GO terms, 42 DEGs) and biological processes (13 GO terms, 41 DEGs) (Figure 2b). KEGG pathway enrichment results revealed that 181 DEGs mapped to pathways including metabolism, human diseases, genetic information processing, environmental information processing, and cellular processes (Figure 2c). COG enrichment analysis categorized DEGs into 19 functional groups, with the most significant enrichment in function unknown and metabolism-related categories (Figure 2d). These findings suggested that AcsS regulates global gene expression in V. parahaemolyticus.

Figure 2

As listed in Table 2, several DEGs implicated in biofilm formation were identified, including tpdA, flgD, flgE, motY, mshG, capF, and VP0226. Specifically, tpdA encodes a trigger PDE involved in biofilm formation and c-di-GMP degradation (). The genes flgD, flgE, and motY are associated with the polar flagellar system, while mshG belongs to the type IV pili gene cluster. Additionally, capF and VP0226 contribute to capsular polysaccharide (CPS) synthesis. However, AcsS is unlikely to promote biofilm formation solely through polar flagella, type IV pili, and CPS, given the extensive gene networks governing these structures in V. parahaemolyticus (). The cpsA-K gene cluster, directly associated with the wrinkled colony phenotype and regulated by TpdA (), further underscores this complexity. Consequently, tpdA and cpsA (VPA1403) were selected as focal genes for subsequent experiments.

Table 2

Gene IDNameFold changeProduct
c-di-GMP metabolism
VP1881tpdA5.84EAL domain protein
Cell motility
VP0777flgD0.48Flagellar basal body rod modification protein
VP0778flgE0.50Flagellar hook protein FlgE
VPA1539motY2.19Sodium-type flagellar protein MotY
Type IV pili
VP2700mshG0.48MSHA biogenesis protein MshG
Capsule polysaccharide (CPS)
VP0225capF0.44Capsular polysaccharide biosynthesis protein
VP02260.45Rhamnosyl transferase
Regulatory functions
VP00802.00Sigma-54 interacting response regulator
VP0350calR3.99Leucine transcriptional activator
VP03582.04DeoR family transcriptional regulator
VP0569phoB0.33DNA-binding response regulator PhoB
VP0570phoR0.29Phosphate regulon sensor protein
VP12440.49Response regulator
VP23872.02DeoR family transcriptional regulator
VP2885fis0.44DNA-binding protein Fis
VPA0148cpxR0.43Transcriptional regulator CpxR
VPA0149cpxA0.47Two-component system sensor kinase
VPA02490.39Transcriptional activator
VPA02512.11LysR family transcriptional regulator
VPA03550.32Transcriptional regulator
VPA14722.14MerR family transcriptional regulator

Selected DEGs.

Regulation of tpdA and cpsA by AcsS and TpdA

The RT-qPCR results showed that the mRNA level of tpdA significantly increased in ΔacsS and ΔacsSΔtpdA but decreased in ΔtpdA compared to WT (Figure 3a). Specifically, tpdA mRNA levels were significantly lower in ΔacsSΔtpdA than in ΔacsS and significantly higher than in ΔtpdA (p < 0.05) (Figure 3a). Furthermore, the mRNA level of cpsA significantly decreased in ΔacsS and increased in ΔtpdA, whereas no significant change was observed in ΔacsSΔtpdA compared to WT (Figure 3a). Compared to ΔtpdA, the cpsA mRNA level was significantly elevated in ΔacsSΔtpdA but significantly reduced relative to ΔacsS (p < 0.05) (Figure 3a). As further determined by LacZ fusion assay (Figure 3b), the promoter activity of tpdA significantly increased in ΔacsS and ΔacsSΔtpdA but significantly decreased in ΔtpdA compared to WT (p < 0.01). Additionally, the promoter activity of tpdA was significantly lower in ΔacsSΔtpdA than in ΔacsS and higher than in ΔtpdA (p < 0.01) (Figure 3b). For cpsA, promoter activity significantly decreased in ΔacsS and ΔacsSΔtpdA but increased in ΔtpdA compared to WT (p < 0.01). Notably, cpsA promoter activity in ΔacsSΔtpdA was elevated relative to ΔacsS but reduced compared to ΔtpdA (p < 0.01) (Figure 3b). Both assays demonstrated that tpdA expression in ΔacsSΔtpdA exceeds WT levels, suggesting that AcsS’s negative regulatory effect on tpdA outweighs TpdA’s positive regulation. Regarding cpsA expression, a discrepancy was observed between the RT-qPCR and LacZ fusion results: RT-qPCR revealed no significant difference in cpsA mRNA levels between ΔacsSΔtpdA and WT, whereas LacZ assays showed significantly lower cpsA promoter activity in ΔacsSΔtpdA than in WT. This inconsistency warrants consideration. Possible explanations include: () the lacZ fusion construct might lack regulatory elements present in the native chromosomal context that modulate mRNA stability or post-transcriptional processing, leading to a discrepancy between promoter activity measured by the reporter and steady-state mRNA levels; or () post-transcriptional regulatory mechanism (e.g., affecting mRNA stability or translation efficiency) could differentially influence the endogenous cpsA mRNA measured by RT-qPCR versus the heterologous lacZ mRNA transcribed from the cpsA promoter fusion. Collectively, despite this discrepancy for cpsA in the double mutant, the results consistently indicate that AcsS suppresses tpdA expression but activates cpsA, independent of TpdA. Conversely, TpdA promotes its own expression while repressing cpsA, regardless of AcsS.

Figure 3

AcsS indirectly represses tpdA transcription but directly activates cpsA transcription

The results of EMSA showed that His-AcsS dose-dependently binds to the regulatory DNA fragment of cpsA but does not bind to the regulatory DNA region of tpdA or the coding region of 16S rRNA (used as a negative control) (Figure 4a). Additionally, a two-plasmid lacZ reporter assay demonstrated that expressing acsS from pBAD33-acsS in EC100 significantly decreased tpdA promoter activity while increasing cpsA promoter activity (Figure 4b). Although the two-plasmid lacZ fusion assay is a widely used method to validate direct regulatory interactions (Zhang et al., 2021; ; ), results obtained in heterologous hosts like EC100 must be interpreted cautiously. Potential confounding factors include regulator overexpression and incompatibility or unintended interactions between the regulator and the host’s cellular machinery. Collectively, these findings confirm that AcsS directly activates the transcription of cpsA and indirectly represses tpdA transcription.

Figure 4

AcsS promotes c-di-GMP production whereas TpdA degrades c-di-GMP in Vibrio parahaemolyticus

A previous study demonstrated that deletion of tpdA led to a 33% increase in c-di-GMP levels compared to WT during exponential growth (). The data from this study also showed that the c-di-GMP level in ΔtpdA was significantly higher than in WT (p < 0.05) (Figure 5). Additionally, the c-di-GMP levels in ΔacsS were significantly reduced compared to WT, ΔtpdA and ΔacsSΔtpdA (p < 0.05) (Figure 3). Furthermore, the c-di-GMP level in ΔacsSΔtpdA was significantly lower than that in ΔtpdA (p < 0.05) (Figure 3). However, no significant differences were detected when comparing ΔacsSΔtpdA with WT (p > 0.05) (Figure 5). These findings indicate that TpdA degrades c-di-GMP in V. parahaemolyticus independently of AcsS, while AcsS stimulates c-di-GMP synthesis regardless of TpdA’s presence.

Figure 5

AcsS-dependent biofilm formation is independent of TpdA

To determine whether AcsS-dependent biofilm formation is mediated by TpdA, we compared the biofilm-forming abilities of the WT, ΔacsS, ΔtpdA and ΔacsSΔtpdA strains. As depicted in Figure 6a, the ΔacsS and ΔacsSΔtpdA strains displayed significantly reduced CV staining compared to the WT and ΔtpdA strains, respectively (p < 0.05). In contrast, the ΔacsSΔtpdA strain exhibited significantly enhanced CV staining relative to the ΔacsS strain (p < 0.01). However, no significant difference was observed between the ΔtpdA and WT strains (p > 0.05). Additionally, the colonies of WT and ΔtpdA were more wrinkled than those of the ΔacsS and ΔacsSΔtpdA strains (Figure 6b). The colonies of ΔtpdA and ΔacsSΔtpdA were slightly wrinkled compared to those of the WT and ΔacsS strain, respectively (Figure 6b). These results suggest that AcsS-dependent biofilm formation is independent of TpdA, while TpdA appears to partially suppress biofilm formation in the ΔacsS genetic background.

Figure 6

TpdA inhibits the expression of acsS

To determine whether TpdA regulates acsS, we analyzed acsS mRNA levels by RT-qPCR. As shown in Figure 7, the mRNA levels of acsS were significantly elevated in the ΔtpdA strain compared to the WT strain (p < 0.01), suggesting that the expression of acsS was under the negative control of TpdA in V. parahaemolyticus.

Figure 7

Discussion

LysR-type transcriptional regulators are crucial for a wide range of cellular processes, including metabolism, motility, biofilm formation, and virulence, through their control of gene transcription (). In this study, the data demonstrated that the LysR-type transcriptional regulator AcsS exerts a positive regulatory effect on biofilm formation in V. parahaemolyticus (Figure 1). Notably, the expression of AcsS is significantly induced by low-salt growth conditions and L-arabinose, both of which greatly affect biofilm formation in this pathogen (Zhang et al., 2023; Yang et al., 2010). Therefore, further research is necessary to ascertain whether the effects of salinity and L-arabinose on biofilm formation is mediated through the regulation of AcsS.

RNA-seq analysis revealed that AcsS controls 235 genes implicated in a variety of cellular pathways (Supplementary Table S1). However, only a subset of these genes is linked to biofilm formation, including three flagellar genes, one type IV pili-related gene, two CPS biosynthesis genes, and one gene linked to c-di-GMP metabolism (Table 2). Mature biofilm development requires polar and lateral flagella (Yildiz and Visick, 2009; ). Type IV pili serve as adhesins that facilitate formation of biofilms on surfaces, particularly chitin (; ). CPS plays a pivotal role in controlling biofilm size by limiting the expansion of mature biofilms (). However, the synthesis of flagella, type IV pili, and CPS involves multiple genes (). It remains unclear whether AcsS has a global impact on the overall synthesis of these structures under the tested conditions, as its regulatory effects appear limited to individual genes within these intricate systems. AcsS indirectly represses the transcription of tpdA, which encodes a PDE that degrades c-di-GMP, thereby inhibiting biofilm formation (). In a feedback loop, TpdA inhibits the expression of both acsS and its own gene (Figures 3, 4, 7). AcsS-dependent c-di-GMP production may be mediated through TpdA, whereas TpdA inhibits c-di-GMP production independently of AcsS (Figure 5). Moreover, AcsS-dependent biofilm formation is not influenced by TpdA, although TpdA partially inhibits biofilm formation in the ΔacsS background (Figure 6). Consequently, AcsS and TpdA coordinately regulate c-di-GMP levels, implicating this signaling molecule as one mechanism through which AcsS controls biofilm formation.

Deletion of acsS alone (ΔacsS) or in combination with acsS and tpdAacsSΔtpdA) resulted in smoother colony morphology compared to WT (Figures 1, 6). This phenotype aligns with reduced EPS production (). In V. parahaemolyticus, the cpsA-K and scvA-O gene clusters are responsible for the production of EPS (). However, only the cps locus drives EPS phase variation, which mediates transitions between smooth and wrinkled colony morphologies (; Zhang et al., 2022). This variation influences various behaviors of V. parahaemolyticus, including motility, biofilm formation, and virulence gene expression (Zhang et al., 2022; ). The data presented here showed that AcsS directly activates cpsA transcription irrespective of TpdA, while TpdA represses cpsA expression independently of AcsS (Figures 3, 4). This antagonistic regulatory relationship suggests that AcsS-mediated control of the cpsA-K operon is a key mechanism underpinning its role in biofilm regulation.

Biofilm formation by V. parahaemolyticus is intricately controlled by a variety of factors, including nutritional conditions like salinity (), metal ion concentrations (; ), and carbon sources (Zhang et al., 2023); environmental parameters like pH () and temperature (); and regulatory proteins such as AphA (), OpaR (Zhang et al., 2021), QsvR (Zhang et al., 2023), OxyR (), CpsQ (), ToxR (), and H-NS (Zhang et al., 2018). QsvR directly represses the transcription of aphA and toxR, while activating cpsQ and opaR (; Zhang et al., 2019). Furthermore, VPA0607 and qsvR are transcribed together as the VPA0607-qsvR operon (Zhang et al., 2023). AphA indirectly activates the transcription of VPA0607 at low cell density, whereas OpaR and QsvR directly repress it at high cell density (Zhang et al., 2023). This intricate interplay of regulators is particularly crucial for the precise control of biofilm-related gene expression. In this study, RNA-seq data revealed that AcsS regulates 12 putative regulatory genes, including calR, phoBR, and fis (Table 2). Among these, CalR regulates virulence (Zhang et al., 2017), swarming motility (), and biofilm formation (unpublished data). PhoB and PhoR form a two-component signal transduction system (). In V. cholerae, PhoB positively regulates motility and negatively controls biofilm formation and c-di-GMP production (). In V. parahaemolyticus, PhoR is involved in regulating the expression of 1,122 genes, including those responsible for lateral flagella (Zhang et al., 2020). V. parahaemolyticus Fis functions as a global regulator, influencing a variety of biological processes such as quorum sensing, the modulation of swimming and swarming motility, and metabolic pathways (). These findings suggest that AcsS may interact with CalR, PhoB/PhoR, Fis, and other regulators to form a coordinated network governing biofilm development. Further studies are needed to dissect these potential interactions and their mechanistic roles.

In conclusion, this study demonstrates that AcsS and TpdA coordinately regulate biofilm formation in V. parahaemolyticus (Figure 8). AcsS indirectly represses the transcription of tpdA, which encodes a PDE that degrades c-di-GMP, thereby promoting the production of c-di-GMP. In a feedback loop, TpdA inhibits the expression of acsS. Additionally, AcsS directly activates the transcription of cpsA independently of TpdA, while TpdA antagonizes cpsA expression. Therefore, AcsS promotes biofilm formation in V. parahaemolyticus by regulating the transcription of cpsA-K and tpdA, as well as the production of c-di-GMP. The data enhance our understanding of the regulatory networks controlling biofilm formation in V. parahaemolyticus and highlight AcsS as a key regulator of this process. Importantly, disrupting this regulatory circuit could attenuate biofilm formation, thereby reducing environmental persistence and seafood contamination by this pathogen. Future studies should explore small-molecule inhibitors targeting these regulators to validate their translational potential.

Figure 8

; ).

Statements

Data availability statement

The original data presented in the study are included in the article/Supplementary material. The raw data of RNA-seq have been deposited in the NCBI repository under accession number PRJNA913656.

Author contributions

BN: Formal analysis, Data curation, Investigation, Project administration, Resources, Writing – original draft. JC: Data curation, Formal analysis, Investigation, Writing – original draft. YinZ: Investigation, Writing – original draft. WL: Investigation, Resources, Writing – original draft. ZT: Investigation, Resources, Writing – original draft. RL: Funding acquisition, Project administration, Resources, Supervision, Validation, Writing – original draft. YiqZ: Conceptualization, Formal analysis, Methodology, Supervision, Validation, Visualization, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Key Research and Development Program of China (Grand No. 2023YFD1801302), the Nantong University Special Research Fund for Clinical Medicine (Grant No. 2022JZ010), and the Research and Development of the Etiology and Epidemic Prevention Technology System for Infectious Diseases on the Qinghai-Tibet Plateau (Grand No. 20220254). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2025.1652011/full#supplementary-material

References

Summary

Keywords

Vibrio parahaemolyticus, biofilm, AcsS, regulation, TpdA, c-di-GMP

Citation

Ni B, Chang J, Zhou Y, Li W, Tian Z, Lu R and Zhang Y (2025) The coordinated regulatory impact of AcsS and TpdA on biofilm formation in Vibrio parahaemolyticus. Front. Microbiol. 16:1652011. doi: 10.3389/fmicb.2025.1652011

Received

25 June 2025

Accepted

11 August 2025

Published

20 August 2025

Volume

16 - 2025

Edited by

Giovanna Batoni, University of Pisa, Italy

Reviewed by

Manuel Espinosa-Urgel, Spanish National Research Council (CSIC), Spain

Wenxiu Zhu, Shenyang Normal University, China

Updates

Copyright

*Correspondence: Renfei Lu, ; Yiquan Zhang,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics